Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 202

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027

The global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period. Market growth is driven by factors such as increased production diagnostic products and government initiatives. On the other hand, challenges associated with urinalysis market like changing regulatory landscapes is the major factors hampering the growth of this market.

“The consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period”

The urinalysis market is segmented into consumables and instruments. In 2021, consumables segment accounted for the highest growth rate in the urinalysis market. Increase in number of research & development and product approval and increased focus on reducing diseases like kidney and liver disease cases which are also associated with age increased age are major factor contributing to the growth of this segment.

“The pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market, by test type, during the forecast period”

The urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. In 2021, pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market. Increasing funds for research, increasing awareness on fertility and pregnancy testing in women and increasing adoption of rapid pregnancy tests is major factor contributing to the growth of this segment.

“The disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period”

The urinalysis market is segmented into disease screening and pregnancy & fertility. In 2021, disease screening segment accounted for the highest growth rate in the urinalysis market. Increasing funding for the prevention of diseases like diabetes and Kidney diseases, growth in the number of diagnostic and imaging centers and improving healthcare infrastructure in emerging countries are major factor contributing to the growth of this segment.

“The diagnostic laboratories segment accounted for the highest growth in the urinalysis market, by end user, during the forecast period”

The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the highest growth rate in the urinalysis market. Emerging markets offer lucrative growth opportunities, growing number of regulatory approvals for diagnostic technologies and rising incidence of life style related disorders are major factors contributing to the growth of this segment.

“Asia Pacific: The fastest-growing region in urinalysis market”

The global urinalysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of diabetes and supportive government policies in the healthcare sector is driving the growth of the urinalysis market in this region.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:

Siemens Healthineers AG (Germany)

F. Hoffmann-La Roche Ltd. (Switzerland)

Cardinal Health, Inc. (US)

Abbott Laboratories (US)

Danaher Corporation (US)

Sysmex Corporation (Japan)

Thermo Fisher Scientific, Inc. (US)

Quidel Corporation (US)

Becton, Dickinson and Company (US)

Bio-Rad Laboratories, Inc. (US)

EKF Diagnostics (UK)

Research Coverage:

This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.